Gene Therapy Startup Lacerta Therapeutics Raises $30M in Equity Financing from Sarepta (MedCityNews)
A startup based out of the University of Florida developing viral vector-based gene therapies has drawn an equity investment from a larger, commercial-stage drugmaker. Lacerta Therapeutics closed on the $30 million investment round, made by Cambridge, Massachusetts-based Sarepta Therapeutics, which gives Sarepta rights to multiple Lacerta central nervous system gene therapy programs. The announcement came […]
Sarepta Dives Deeper into Gene Therapy (PharmaPhorum)
Sarepta Therapeutics has handed $30 million to UF startup and Sid Martin Biotech resident client Lacerta in exchange for a group of gene therapies, including a Pompe disease candidate. According to the agreement Sarepta will make an equity investment of $30 million in Lacerta Therapeutics gaining rights to two unnamed CNS-targeted gene therapy programs including […]
Blood Test May Eliminate Need for CT Scans after TBI (Healio)
The University of Rochester School of Medicine and Dentistry studied the accuracy of a TBI diagnostic blood test created by UF startup and Sid Martin Biotech graduate Banyan Biomarkers. A novel blood test predicted the absence of intracranial injuries on head CT scan after suspected traumatic brain injury with high accuracy, according to findings published […]
New Diagnostic Blood Test Developed for Concussions (eHealth News)
UF biotech company, Banyan Biomarkers, Inc. has developed the first blood test that can be used by physicians to objectively aid in the evaluation of patients with suspected traumatic brain injury (TBI) or concussions. Banyan is a University of Florida startup and a graduate of UF Innovate | Sid Martin Biotech. The Banyan Brain Trauma Indicator® […]
Ology Bioservices and RAFA Laboratories Announce FDA Approval of the Atropine Autoinjector as a Medi (BioFlorida)
UF startup and Sid Martin Biotech alum Ology Bioservices, Inc., a biologics contract development and manufacturing organization, and Rafa Laboratories, Ltd., a leading Israeli pharmaceutical company, announced that on July 9, 2018, they received full approval from the U.S. Food and Drug Administration (FDA) for the Atropine Injection, 2mg/0.7mL, Single-Dose Autoinjector. The Atropine Autoinjector initially […]
AxoGen, Inc Common Stock (AXGN) Sets New 1-Year High at $56.85 (Fairfield Current)
UF startup and Sid Martin Biotech alum AxoGen, Inc reported that its Common Stock (NASDAQ:AXGN) shares hit a new 52-week high during mid-day trading on Tuesday. The company traded as high as $56.85 and last traded at $54.90, with a volume of 4762 shares changing hands. The stock had previously closed at $56.60. The company […]
AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrollment Milestone (BioFlorida)
Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has enrolled the first patient of the second cohort in the company’s Phase 1/2 clinical trial evaluating the safety and efficacy of an investigational AAV-based gene therapy for the […]
Captozyme Initiates Clinical Study of Nephure™ Oxalate-Reducing Enzyme (BusinessWire)
UF Innovate incubator graduate Captozyme, Inc. announced that it is initiating a prospective double-blind, randomized, placebo controlled, cross-over study, with Nephure™, an oxalate reducing enzyme, to determine the extent to which Nephure vs. placebo reduces urinary oxalate excretion (mg/24 hour) in healthy subjects who are provided a controlled diet. Captozyme is a graduate of both […]
Assembly Biosciences Initiates Phase 2a Trial for HBV Core Inhibitor (Healio)
UF Innovate | Sid Martin Biotech alumni company Assembly Bioscience announced the initiation of two randomized control phase 2a trials for ABI-H0731, the company’s lead hepatitis B core inhibitor, according to a press release. ABI-H0731 previously demonstrated potent antiviral activity in a phase 1b trial, the results of which were presented at the International Liver […]
Explain Your Brain: New Breakthroughs In TBI Science For Veterans (DisabledVeterans.org)
(This post on DisabledVeterans.org discusses traumatic brain injury and calls the blood test that indicates TBI created by UF startup & Sid Martin Biotech graduate Banyan Biomarkers “great news.”) If you’re a veteran with a traumatic brain injury, or TBI, you know how frustrating it can be. With a range of types and severities, TBI […]